San Raffaele-Telethon gene therapy spinout Genespire has picked up series A funding from Sofinnova Partners to target inherited metabolic diseases and primary immunodeficiencies.

Woodford has faced challenges in selling its shareholdings in spinouts including Oxford Nanopore and Immunocore, but has now lined up Acacia as a potential buyer.

Axa Venture Partners and Orange Digital Ventures backed a $27.2m round that will fund product development and international growth for the employee engagement software provider.

Robocath, which is developing robotic-assisted technology for cardiovascular diseases, has collected capital from investors including TUS-Holdings.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Robocath, which is developing robotic-assisted technology for cardiovascular diseases, has formed a strategic partnership with Microport in connection with a $43.4m round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

NetScientific's pre-tax loss was halved to $6.5m during 2019, and the firm also reported improved cash availability.

Otsuka Pharmaceuticals's McQuade Center for Strategic Research and Development backed the psilocybin-based mental health drug developer through the round.

Terese Hougaard has taken a principal role at the UK-based venture firm after five years at Alphabet unit CapitalG, most recently as a partner.